To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Weight-adjusted dosing of… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection.

Journal article
Authors Martin Lagging
Nina Langeland
Court Pedersen
Martti Färkkilä
Mads Rauning Buhl
Kristine Mørch
Amar P Dhillon
Åsa Alsiö
Kristoffer Hellstrand
Johan Westin
Peer Christensen
Peter Leutscher
Gunnar Norkrans
Published in Hepatology (Baltimore, Md.)
Volume 48
Issue 2
Pages 695
ISSN 1527-3350
Publication year 2008
Published at Institute of Biomedicine, Department of Infectious Medicine
Pages 695
Language en
Keywords Antiviral Agents, administration & dosage, therapeutic use, Body Weight, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Genotype, Hepacivirus, genetics, Hepatitis C, Chronic, blood, drug therapy, pathology, Humans, Interferon Alfa-2a, administration & dosage, therapeutic use, Polyethylene Glycols, administration & dosage, therapeutic use, RNA, Viral, blood, Ribavirin, administration & dosage, therapeutic use, Time Factors
Subject categories Microbiology in the medical area
Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?